Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Development of New Generation of Vaccines for Brucella Abortus Publisher



Gheibi A1 ; Khanahmad H2 ; Kashfi K3 ; Sarmadi M2 ; Khorramizadeh MR4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Biotechnology, School of Advanced Technologies in Medicine (SATiM), Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Molecular, Cellular and Biomedical Sciences, Sophie Davis School of Biomedical Education, City University of New York School of Medicine, New York, United States
  4. 4. Biosensor Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Heliyon Published:2018


Abstract

Brucella abortus is a Gram-negative facultative and intracellular bacteria, it causes bovine brucellosis, a zoonotic disease that is responsible for considerable economic loss to owners of domesticated animals and can cause problems in otherwise healthy humans. There are a few available live attenuated vaccines for animal immunization against brucellosis; however, these have significant side effects and offer insufficient protective efficacy. Thus, the need for more research into the Molecular pathobiology and immunological properties of B. abortus that would lead to the development of better and safer vaccines. In this paper we have reviewed the main aspects of the pathology and the responsive immunological mechanisms, we have also covered current and new prospective vaccines against B. abortus. © 2018
Related Docs
View other Related Docs
1. Design and Characterization of a Recombinant Brucella Abortus Rb51 Vaccine That Elicits Enhanced T Cell-Mediated Immune Response, Vaccines (2022)
2. In Silico Design, Cloning and High Level Expression of L7/L12-Tomp31 Fusion Protein of Brucella Antigens, Research in Pharmaceutical Sciences (2015)
3. A Comparison Between Adjuvant and Delivering Functions of Iron Oxide and Calcium Phosphate Nanoparticles, Using a Model Protein Against Brucella Melitensis, Clinical and Experimental Vaccine Research (2025)
4. Production and Characterization of Monoclonal Antibodies Against Brucella Abortus S (99) Surface Antigens, Iranian Biomedical Journal (2002)
5. The Antibiotic Susceptibility of Brucella Spp. Isolated From Human Samples: A Systematic Review and Meta-Analysis, Iranian Journal of Medical Microbiology (2023)
6. Anti-Nmda Receptor Encephalitis Presenting With Status Epilepticus: Brucellosis As a Possible Triggering Factor: A Case Report, International Journal of Preventive Medicine (2019)
7. Epidemiological Characteristics and Incidence Rate of Brucellosis in Isfahan Province, Iran, 2012, Journal of Isfahan Medical School (2015)
8. Trends of Human Brucellosis in Central Iran (2010-2018), Journal of Research in Medical Sciences (2021)
Experts (# of related papers)
View all Related Experts
Hossein Khanahmad (2)
Ali Jahanian Najafabadi (1)
Other Related Docs
9. Isolation of Brucella Abortus Using Pcr-Rflp Analysis, Iranian Journal of Public Health (2006)
10. Tgf B 1 Genetic Variants Are Associated With an Increased Risk of Acute Brucellosis, Infectious Diseases (2015)
11. An Unusual Presentation of Brucellosis, Involving Multiple Organ Systems, With Low Agglutinating Titers: A Case Report, Journal of Medical Case Reports (2007)
12. Optimization and Comparison of Different Methods and Factors for Efficient Transformation of Brucella Abortus Rb51strain, Advanced Biomedical Research (2019)
13. Clinical and Serological Approach to Patients With Brucellosis: A Common Diagnostic Dilemma and a Worldwide Perspective, Microbial Pathogenesis (2019)